KHSC clinician-scientist recognized at Canadian Cancer Research Conference
Elizabeth Eisenhauer, a pioneering clinician-scientist and an influential voice for cancer research in Canada, is being honoured with the Exceptional Leadership in Cancer Research award from the Canadian Cancer Research Alliance (CCRA).
Dr. Eisenhauer is being recognized for her work as a clinician-scientist and her national leadership roles—President of the National Cancer Institute of Canada, Expert Lead, Research at the Canadian Partnership Against Cancer and Co-chair of the Canadian Cancer Research Alliance—demonstrating her long-standing commitment to enhancing the coordination and quality of cancer research in Canada in order to improve the lives of cancer patients.
A clinician-scientist with the KGH Research Institute and Professor Emerita, Department of Oncology at Queen’s University, Dr. Elizabeth Eisenhauer was the Director of the Investigational New Drug Program for the Canadian Cancer Trials Group from 1982 to 2012. Her work, which fundamentally changed clinical practice worldwide, introduced innovative trial methodologies and endpoints and placed an emphasis on the benefits of team science and timely adoption of evidence-based medicine. From 2006 to 2017, she assumed national leadership roles as President of the National Cancer Institute of Canada (2006-2009), Expert Lead, Research at the Canadian Partnership Against Cancer, and Co-chair of the Canadian Cancer Research Alliance (2008-2017). Most recently Dr. Eisenhauer served as Head and Professor for the Department of Oncology at Queen’s University. She also demonstrated a very personal commitment to research, through her creation of the Edith and Carla Eisenhauer Chair in Clinical Cancer Research at Queen’s University in 2001.
“Dr. Eisenhauer has made a profound impact on the quality of cancer research and treatment in Canada, and around the world,” says Roger Deeley, Vice President, Health Sciences Research, KHSC and President & CEO, KGHRI. “Through her research, her advocacy and her philanthropy, she has advanced knowledge in her chosen field, enhanced quality of life for untold numbers of cancer patients, and been a role model for a generation of clinician-scientists. She is a most deserving recipient of this honour.”
“These awards demonstrate CCRA’s continuing recognition of excellence in cancer research,” says Dr. Sara Urowitz, Executive Director of CCRA. “We take this opportunity to showcase these achievements during our biennial scientific conference so that these awardees can be honoured in the presence of their peers and can serve as a source of inspiration for our new investigators and trainees.”
Dr. Eisenhauer will be presented with her award, along with five other honorees, on Nov. 6 at the CCRA’s Canadian Cancer Research Conference in Vancouver.